Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
136
Publications avec texte intégral
Open Access
53 %
Mots clés
Oligodendrocyte
Centronuclear myopathy
Duchenne muscular dystrophy
Fibrosis
Glucocorticoid-receptor
Antisense oligonucleotide
CTG repeats
Maximal force
Skeletal muscle
CONGENITAL MYATHENIC SYNDROME
Autophagy
Transgenic mouse model
Male
Myotonic dystrophy mouse models
Myotonic Dystrophy
Mice
Expression
Mouse model
Motoneuron
Long read sequencing
Dynamin 2
MBNL
ACETYLCHOLINESTERASE
CRISPR/Cas9
Gene Therapy
Muscular dystrophy
Dilated cardiomyopathy
Dystrophie myotonique
RNA biology
Exercise
Central nervous system
Cell culture model
Therapy
Diaphragm
Muscle
CTG repeat contractions
AAV
Animals
Trinucleotide repeat expansion
Myostatin
Humans
KNOCKOUT MICE
GSK3
Heart
Desmin
Myotonic dystrophy
Myotonic Dystrophy type 1
CRISPRi
In vivo
RNA splicing
Trinucleotide Repeat Expansion
Myelin
Oligodendrocytes
ARN
DMPK
PacBio
Aging
DMSXL mice
Quantitative microdialysis
Antisense oligonucleotides
Brain
Exercice
Dystrophin
BIOLOGIE MOLECULAIRE
CMS
Astrocyte
Neuron
Cell model
Thérapie génique
Astrocytes
Mouse models
Glucocorticoids
Myotonic Dystrophy Type 1
Gene therapy
Hypoxia
Transcriptomics
Myotonic dystrophy type 1
Knockout
Heart failure
Acetylcholinesterase knockout mouse
Glial cells
Glutamate
Gene editing
DM1
Endurance training
PCR
RNA interference
Cardiac muscle
Acute coronary syndrome
Cell penetrating peptide
Brain dysfunction
Dystrophie Myotonique
Intermediate filament
CTG repeat instability
Cytoskeleton
Genotype phenotype correlation
Alternative splicing
Acetylcholinesterase deficiency
GABA
Transgenic mouse